When Should We Start Using Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Diabetic Kidney Disease?
Journal Title: Нирки - Year 2017, Vol 6, Issue 1
Abstract
International guidelines do not recommend angiotensin converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) usage in the first stage of diabetic kidney disease. It shows the view, based on a small statistical sample, that olmesartan (or possibly other ACE inhibitors/ARBs) should be used to prevent the transition of the first stage of diabetic kidney disease to the second one in type 2 diabetes mellitus.
Authors and Affiliations
D. D. Ivanov
Keywords
Related Articles
- EP ID EP208749
- DOI 10.22141/2307-1257.6.1.2017.93781
- Views 80
- Downloads 0
Symposium 172 "Urinary Tract Infections"
Urinary tract infections are one of the largest groups of renal diseases. They occupy a leading place among the human organism infections in general. The main topics of discussion are the classification, etiological fact...
Immunobiological drugs in the treatment of rheumatic diseases
Rheumatic diseases (RD) are among the most common chronic diseases of the musculoskeletal system and connective tissue which are found in both adults and children. The cause of these pathological conditions can be change...
Acetate-free Biofiltration for the Prevention of Intradialytic Hypеrcapnia in a Patient with Limited Pulmonary Reserve
A case of acute hypercapnia occurring during a session of bicarbonate hemodialysis is reported. The 82-year old female patient was affected by cardiac insufficiency, pulmonary hypertension and chronic obstructive lung d...
American Diabetes Association Standards of Medical Care in Diabetes — 2018 Diabetes Care. — 2018 Jan. — 41(S. 1). — https://doi.org/10.2337/dc18-Sint01.
.
Immunoadsorption and Its Application for Desensitizing Incompatible Kidney Transplant Candidates Who Have a Potential Living Donor
Background. Plasmapheresis is widely used to remove potential deleterious antibodies from the blood. Because the volume of treated plasma is limited, plasmapheresis can be replaced by immunoadsorption (IA), a more tediou...